CJC-1295 Dosage Guide
Complete guide to CJC-1295 dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
1 mg – 2 mg
Frequency
Once per week
Route
subcutaneous
Cycle Length
8–12 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
CJC-1295 DAC
1-2mg weekly.
CJC-1295 no DAC (Mod GRF 1-29)
100-300mcg 2-3 times daily.
Administration Method
Subcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.600 ml
Syringe units: 60.0 units
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with CJC-1295 defaults. Adjust values as needed.
Side Effects to Monitor
Water retention, tingling in extremities, potential increase in cortisol and prolactin levels.
Safety Considerations & Risks
May affect blood glucose levels. Long-term effects on pituitary function not fully understood.